Clear Cancer Guidance—Directly From a Medical Oncologist.
CancerAsk bridges the gap between complex data and actionable treatment paths. Led by Dr. Zubair Ali, FCPS & MRCP (Medical Oncology), this virtual practice offers written and video consultations, comprehensive second opinions, and precise breakdowns of your pathology and molecular testing. Expert oncological insights, available to patients and healthcare providers anywhere in the world.
Dr. Zubair Ali
FCPS & MRCP (Medical Oncology)
Report review returned within 24 hours / Consultations 30–45 min / English · Urdu · Hindi
ER 90% PR 60% HER2 IHC 3+.
pT2 N1 M0 Ki-67 25%.
NGS: PIK3CA H1047R detected.
Sentinel node: 2 / 3 positive.
Your tumour is HER2-positive. That's a subtype with dedicated targeted drugs (trastuzumab and others) that meaningfully improve outcomes.
A tumour 2–5 cm, spread to a small number of lymph nodes, with no distant spread. Early-stage and treated with curative intent.
A common, well-studied change. It doesn't change your first treatment, but it opens a specific targeted option later if needed.
The gap between a report and an answer
A diagnosis arrives as dense pages of staging, biomarkers, and mutation names — and very little time to ask what any of it means for you. The information online is scattered, and it's hard to know whom to trust.
Before
- Anxious, confused, unsure whom to trust
- Can't interpret staging, mutation results, or scans
- Treatment choices feel like a coin toss
- Scattered, unreliable information online
After
- Informed, confident, and supported
- You understand your diagnosis and why each step matters
- A clear treatment plan and defined next steps
- A trusted oncologist you can come back to anytime
Six ways to work together
Online oncology consultations
Evidence-based virtual consultations for clarity, guidance, or direction on treatment — by video or in writing.
Personalized report interpretation
Clear, expert explanations of pathology reports, imaging, biomarkers, and genetic testing results.
Second-opinion consultations
An independent specialist review of your diagnosis and treatment plan to support an informed decision.
Cancer education content
Simplified, accurate oncology education for patients, families, and the general public.
Medical writing & oncology content
Professional articles, guides, explainer content, and cancer-focused publications for organisations and platforms.
Clinical updates for professionals
Regular briefings on new trials, breakthrough therapies, and guideline changes — written for fellow clinicians.
From first message to a plan you understand
Book a call or send your reports
Choose a consultation slot, or upload your pathology, imaging, and molecular reports for a pre-assessment. A free 10-minute introductory call is available first.
I review your case
I go through your history and every document in detail before we speak, so the consultation time is spent on your questions — not on reading.
Report review · within 24 hoursWe meet — by video or in writing
We walk through your diagnosis, what each result means, your treatment options, and the reasoning behind them.
Consultation · 30–45 minutesYou receive a written explanation and next steps
A personalized summary in plain language: your situation, the recommended direction, questions to raise with your treating team, and what to watch for.
Written cancer guide · 2–3 daysOptional ongoing support
A monthly follow-up package: WhatsApp and email support, treatment monitoring, report interpretation, and guidance through each treatment cycle.
Ongoing support · monthly subscriptionWhat changes for the people I work with
From a confusing mutation result to the right therapy
A clear roadmap through staging and targeted therapy
Cancer biology that finally made sense
Illustrative cases from practice; identifying details have been changed to protect patient privacy.
Dr. Zubair Ali
Founder of CancerAsk, consultant medical oncologist, and lead cancer educator. My work combines clinical oncology with clear communication and professional cancer writing — so the guidance you get is expert, evidence-based, and genuinely understandable. Not general health advice: interpretation grounded in day-to-day clinical practice.
Questions people ask
Is an online cancer consultation safe?
Yes. An online consultation is for understanding your diagnosis, reviewing reports, and thinking through treatment options — not for emergencies or hands-on care. It works alongside your treating team, giving you the time and explanation a busy clinic often can't.
Can you interpret my biopsy or mutation report?
Yes. Personalized interpretation of pathology, imaging, biomarkers, and next-generation sequencing results is a core service. You'll get a plain-language explanation of what each finding means for your situation and your options.
Are you a licensed oncologist?
Yes. CancerAsk is run by Dr. Zubair Ali, FCPS and MRCP (Medical Oncology), a practising consultant oncologist with experience in solid tumours and malignant haematology, including lymphoma and myeloma. See the full profile.
How accurate is online guidance?
The guidance is evidence-based and drawn from current oncology practice and published research. It is specialist interpretation of your information — a second opinion and an explanation — and is meant to support, not replace, the decisions made with your treating physician.
How fast will I get my report review?
A report review is returned within 24 hours. Consultations run 30–45 minutes, and a written cancer guide takes 2–3 days.
Do you offer follow-up support?
Yes — an optional monthly package with WhatsApp and email support, treatment monitoring, ongoing report interpretation, and guidance through each treatment cycle.
Is my medical data secure?
Your documents are used only to prepare and deliver your consultation, are never shared without your consent, and can be deleted on request. See the Privacy Policy for details.
Can you help me choose between treatment options?
Yes. Much of the work is laying out the realistic options, the trade-offs, and the reasoning — so you can have a clearer, more confident conversation with your treating team.